FDA Import Refusal AEK-8058665-2/11/1 — ABBVIE CARE
The FDA refused shipment AEK-8058665-2/11/1 from ABBVIE CARE (Canada) on Dec 27, 2024. The refused product falls under Drugs and Biologics — RISANKIZUMAB-RZAA. Cited charge: 75 This firm has 3 other import refusals on record.
Refusal details
- Date
- Dec 27, 2024
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 58MCY09 RISANKIZUMAB-RZAA
- Charges
- 75